In Silico Models for Designing and Discovering Novel Anticancer Peptides

By A. Tyagi, P. Kapoor, Kumardeep Chaudhary, A. Gautam, G. Raghava. Scientific Reports, 2013

297 citations recorded by the source corpus.

Use of therapeutic peptides in cancer therapy has been receiving considerable attention in the recent years. Present study describes the development of computational models for predicting and discovering novel anticancer peptides. Preliminary analysis revealed that Cys, Gly, Ile, Lys and Trp are dominated at various positions in anticancer peptides. Support vector machine models were developed using amino acid composition and binary profiles as input features on main dataset that contains experimentally validated anticancer peptides and random peptides derived from SwissProt database. In addition, models were developed on alternate dataset that contains antimicrobial peptides instead of random peptides. Binary profiles-based model achieved maximum accuracy 91.44% with MCC 0.83. We have developed a webserver, which would be helpful in: (i) predicting minimum mutations required for improving anticancer potency; (ii) virtual screening of peptides for discovering novel anticancer peptides and (iii) scanning natural proteins for identification of anticancer peptides (http://crdd.osdd.net/raghava/anticp/).

Subfields: Microbiology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/2ec590bb7ba3484d50b2efaae077fe85d4fdbcb6

Citations in the corpus